EUVIMEDEUVIMED entdecken
Scoping ReviewOpen Access · CC BY 4.0

A Scoping Review of Pharmacist‐Based Interprofessional Interventions for Management of Cardiovascular‐Kidney‐Metabolic Conditions

Wendy L St Peter iD, Joshua J Neumiller iD, Radica Alicic, Sheryl L Chow, Hadley Dowell, O Kenrik Duru, Patrick Gee, Roy O Mathew, Susanne B Nicholas, Janani Rangaswami, Glenda V Roberts, Muthiah Vaduganathan und 1 weitere

JACCP: JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY · 2026-04 · 9 (4)

DOI: 10.1002/jac5.70198 ↗

Kurz gefasst

Scoping Review in der Zeitschrift JACCP: JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY, online erschienen am 11.03.2026. Verfasst von Wendy L St Peter und 12 weiteren Autor:innen. Beteiligte Einrichtung: College of Pharmacy, University of Minnesota, Minneapolis, Minnesota, USA. Hauptthemen laut MEDLINE: Pharmacists, Cardiovascular Diseases, Renal Insufficiency, Chronic, Patient Care Team. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Boehringer Ingelheim.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Co‐existence of multiple cardiovascular‐kidney‐metabolic (CKM) conditions, such as chronic kidney disease (CKD), type 2 diabetes (T2D), and cardiovascular disease, is common. The interconnected nature of CKM conditions emphasizes the need for an interprofessional approach to patient care. As the prevalence of people with CKM conditions continues to rise in the United States and the burden on the health care system increases, clinical pharmacists are well‐positioned to provide support within interprofessional teams and improve patient access to care through delivery of education, assessments and monitoring, and optimal initiation and maintenance of guideline‐directed medical therapy (GDMT).

Methods

This scoping review explored interprofessional team‐based interventions that incorporated pharmacists into the management of CKM conditions in the U.S. Searches were conducted in Embase and MEDLINE for relevant studies published in English between January 1, 2015 and February 14, 2025, in a patient population with > 5% of patients with both CKD and one or more cardiovascular or metabolic conditions. Outcomes investigated included estimated glomerular filtration rate, urine albumin‐to‐creatinine ratio, glycated hemoglobin, and systolic and diastolic blood pressure, as well as patient and physician satisfaction with pharmacist interventions.

Results

A total of 28 studies met the eligibility criteria, including 18 randomized clinical trials, 4 pilot studies, and 6 observational studies. Effective interventions generally included longitudinal follow‐up with multiple pharmacist visits over time, comprehensive pharmacist involvement including patient assessment, monitoring, and medication management, and direct deployment of pharmacist‐led interventions through collaborative practice agreements.

Conclusions

This scoping review demonstrates an integral and direct role for pharmacists in improving outcomes for patients with CKM conditions in interprofessional settings. However, there is a need for more robust studies that investigate cardiovascular, kidney, and metabolic outcomes in these patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PharmacistsCardiovascular DiseasesRenal Insufficiency, ChronicPatient Care TeamInterprofessional RelationsHumansDiabetes Mellitus, Type 2Professional Role

Stichwörter der Autor:innen

cardiovascular diseasechronic kidney diseaseholistic healthhypertensionmedication therapy managementpatient care teamtype 2 diabetes

Autor:innen und Institutionen

  • College of Pharmacy, University of Minnesota, Minneapolis, Minnesota, USA.
  • College of Pharmacy and Pharmaceutical Sciences, Washington State University, Spokane, Washington, USA.
  • Providence Medical Research Center, Providence Health Care, University of Washington, Spokane, Washington, USA.
  • Pharmacy Practice and Administration, Western University of Health Sciences, Pomona, California, USA.
  • David Geffen School of Medicine, University of California, Los Angeles, California, USA.
  • Patient Author, iAdvocate, Inc., North Chesterfield, Virginia, USA.

ORCID-Profile: Wendy L St Peter, Joshua J Neumiller

Förderung

  • Boehringer Ingelheim

Zitieren

APA

St Peter, W. L., Neumiller, J. J., Alicic, R., Chow, S. L., Dowell, H., Duru, O. K., Gee, P., Mathew, R. O., Nicholas, S. B., Rangaswami, J., Roberts, G. V., Vaduganathan, M., & Tuttle, K. R. (2026). A Scoping Review of Pharmacist‐Based Interprofessional Interventions for Management of Cardiovascular‐Kidney‐Metabolic Conditions. JACCP: JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY, 9(4). https://doi.org/10.1002/jac5.70198

Vancouver

St Peter WL, Neumiller JJ, Alicic R, Chow SL, Dowell H, Duru OK, et al. A Scoping Review of Pharmacist‐Based Interprofessional Interventions for Management of Cardiovascular‐Kidney‐Metabolic Conditions. JACCP: JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY. 2026;9(4). doi:10.1002/jac5.70198

BibTeX
@article{StPeter2026,
  author = {St Peter, Wendy L and Neumiller, Joshua J and Alicic, Radica and Chow, Sheryl L and Dowell, Hadley and Duru, O Kenrik and Gee, Patrick and Mathew, Roy O and Nicholas, Susanne B and Rangaswami, Janani and Roberts, Glenda V and Vaduganathan, Muthiah and Tuttle, Katherine R},
  title = {A Scoping Review of Pharmacist‐Based Interprofessional Interventions for Management of Cardiovascular‐Kidney‐Metabolic Conditions},
  journal = {JACCP: JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY},
  year = {2026},
  volume = {9},
  number = {4},
  doi = {10.1002/jac5.70198}
}
Kostenlos starten →